Ixazomib and lenalidomide maintenance therapy in multiple myeloma

被引：2
|
作者：
Parrondo, Ricardo D. [1 ]
Alegria, Victoria [1 ]
Roy, Vivek [1 ]
Sher, Taimur [1 ]
Chanan-Khan, Asher A. [1 ]
Ailawadhi, Sikander [1 ]
机构：
[1] Mayo Clin Florida, Deparment Hematol Oncol, Mangurian Bldg,3rd Floor,4500 San Pablo Rd S, Jacksonville, FL 32224 USA
来源：
ANNALS OF HEMATOLOGY | 2021年 / 100卷 / 03期
关键词：
STEM-CELL TRANSPLANTATION;
D O I：
10.1007/s00277-020-04340-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：851 / 853
页数：3
相关论文
共 50 条
  • [11] LENALIDOMIDE AS CONSOLIDATION/MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS
    Gagliardi, A.
    Della Cioppa, P.
    Lucania, A.
    Villa, M. R.
    Esposito, M.
    Improta, S.
    Izzo, G. Nitrato
    Mastrullo, L.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [12] Lenalidomide maintenance for multiple myeloma
    Brower, Vicki
    [J]. LANCET ONCOLOGY, 2012, 13 (06): : E238 - E238
  • [13] Ixazomib versus Lenalidomide or Ixazomib and Lenalidomide combination as maintenance regimen for patients with multiple myeloma: interim analysis of a multi-center prospective study in China
    Zhuang, Zhe
    Yu, Hong
    Liu, Qinhua
    Zou, Dongmei
    Shi, Lei
    Tian, Ying
    Dong, Fei
    Ma, Yanping
    Tian, Wei-wei
    Feng, Ru
    Liu, Shuangjiao
    Liu, Hui
    Ma, Liang-Ming
    Jing, Hongmei
    Chen, Wenming
    Wu, Yin
    Bao, Li
    Sun, Wanling
    Fu, Rong
    Zhuang, Junling
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S113 - S113
  • [14] Ixazomib versus lenalidomide or ixazomib and lenalidomide combination as maintenance regimen for patients with multiple myeloma: interim analysis of a multi-center prospective study in China
    Zhuang, Zhe
    Tian, Ying
    Yu, Hong
    Shi, Lei
    Tian, Wei-wei
    Liu, Qinhua
    Zou, Dongmei
    Dong, Fei
    Ma, Yanping
    Feng, Ru
    Liu, Shuangjiao
    Liu, Hui
    Jing, Hongmei
    Sun, Wanling
    Ma, Liang-Ming
    Bao, Li
    Wu, Yin
    Chen, Wenming
    Zhuang, Junling
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S54 - S55
  • [15] Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China
    Zhuang, Zhe
    Tian, Ying
    Tian, Wei-wei
    Yu, Hong
    Zou, Dongmei
    Liu, Qinhua
    Shi, Lei
    Dong, Fei
    Ma, Yanping
    Feng, Ru
    Liu, Shuangjiao
    Liu, Hui
    Jing, Hongmei
    Bao, Li
    Sun, Wanling
    Fu, Rong
    Ma, Liangming
    Chen Wenming
    Wu, Yin
    Zhuang, Junling
    [J]. BLOOD, 2021, 138
  • [16] Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China
    Zhe Zhuang
    Ying Tian
    Hong Yu
    Lei Shi
    Tian, Wei-wei
    Liu, Qinhua
    Zou, Dongmei
    Fei Dong
    Ma, Yanping
    Ru Feng
    Liu, Shuangjiao
    Hui Liu
    Jing, Hongmei
    Sun, Wanling
    Ma, Liangming
    Li Bao
    Rong Fu
    Yin Wu
    Chen Wenming
    Zhuang, Junling
    [J]. BLOOD, 2022, 140 : 12637 - 12639
  • [17] Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Post-Transplant Myeloma Patients
    Patel, Krina K.
    Shah, Jatin J.
    Feng, Lei
    Lee, Hans C.
    Manasanch, Elisabet M.
    Olsem, Jasper
    Morphey, Ashley
    Huo, Xiao Jiao
    Thomas, Sheeba K.
    Bashir, Qaiser
    Qazilbash, Muzaffar H.
    Weber, Donna M.
    Orlowski, Robert Z.
    [J]. BLOOD, 2021, 138
  • [18] Update on a Phase II Study of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Patel, Krina K.
    Shah, Jatin J.
    Feng, Lei
    Lee, Hans C.
    Manasanch, Elisabet E.
    Thomas, Sheeba K.
    Weber, Donna M.
    Munoz, Silvia C.
    Morphey, Ashley
    Bashir, Qaiser
    Qazilbash, Muzaffar H.
    Orlowski, Robert Z.
    [J]. BLOOD, 2017, 130
  • [19] Phase II Study of the Combination of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Shah, Jatin J.
    Feng, Lei
    Weber, Donna
    Thomas, Sheeba K.
    Wang, Michael
    Turturro, Francesco
    Qazilbash, Muzaffar H.
    Shah, Nina
    Bashir, Qaiser
    Popat, Uday R.
    Manasanch, Elisabet E.
    Munoz, Silvia C.
    Landry, Ashley
    Mendoza, Kathleen
    Nieto, Yago
    Champlin, Richard E.
    Orlowski, Robert Z.
    [J]. BLOOD, 2015, 126 (23)
  • [20] Ixazomib versus lenalidomide or ixazomib and lenalidomide combination as maintenance regimen for transplant-ineligible multiple myeloma: update of a multi-center prospective study in China
    Zhuang, Zhe
    Tian, Ying
    Yu, Hong
    Shi, Lei
    Tian, Wei-wei
    Liu, Qinhua
    Zou, Dongmei
    Dong, Fei
    Feng, Ru
    Ma, Yanping
    Liu, Shuangjiao
    Liu, Hui
    Jing, Hongmei
    Sun, Wanling
    Ma, Liang-Ming
    Bao, Li
    Fu, Rong
    Wu, Yin
    Chen, Wenming
    Zhuang, Junling
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S104 - S104
12345